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Respiratory syncytial virus (RSV) is an RNA virus that belongs to the Pneumovirus genus 
of  the Paramyxoviridae family. The aim of  this study was to evaluate the expressions of  
inducible nitric oxide synthetase (iNOS), CD3 (pan T cells), and CD8 (cytotoxic T cells) 
in lamb lungs naturally infected with RSV using immunohistochemistry (IHC). For this 
purpose, 100 pneumonic and 10 control lung tissue samples were taken from lambs 
slaughtered in the slaughterhouse after macroscopic examination. The streptavidin–
peroxidase method (ABC) was used for IHC staining, and it revealed RSV positivity 
in 18 of  100 examined lungs with pneumonia (18%). These positive cases were then 
immunostained for iNOS, CD3, and CD8, and compared to controls. In all these cases, 
an increase in iNOS expression (100%) was detected, the higher number of  CD3+ T 
lymphocytes was detected in 14 (78%) cases while CD8+ T lymphocytes were detected 
in fi ve (28%) cases, only. Given the increase of  iNOS immunoexpression in all RSV-
positive cases and increase in the number of  CD3+ T lymphocytes in most cases, it was 
concluded that iNOS and CD3+ T lymphocytes play an important role in the immune 
response in lamb pneumonia with naturally occurring RSV infection. With this study, 
the role of  the mentioned markers was evaluated for the fi rst time in lambs naturally 
infected with RSV.
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INTRODUCTION
Respiratory diseases in sheep cause major economic losses in the sheep industry in many 
countries [1]. Respiratory syncytial virus (RSV), a pneumovirus of  the Paramyxoviridae 
family, is an important respiratory pathogen in humans [2], and bovine, ovine, and 
caprine RSV types have been identifi ed in ruminants [3,4]. Serological research has 
revealed that RSV is common in sheep in Turkey [1,5]. 
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It has been emphasized that an adaptive immune response should be developed for 
control and clearance of  RSV infections [6]. Researchers have stated that there may 
be differences in the functionality of  the cells collected at the site of  infection, and 
these differences may play a key role in RSV infection [7]. It has been experimentally 
demonstrated that macrophages, neutrophils, and helper and cytotoxic T lymphocyte 
cells are involved in the immune response in newborn lambs infected with the human 
RSV strain [7]. Bovine RSV-infected calves show increased CD8 T lymphocyte 
infi ltration in the lungs, trachea, and nasopharynx [8]. In mice and humans, CD8 T 
cells have been reported to mediate the elimination of  primary RSV infection [9].
CD3 T lymphocytes, which play a role in the formation of  the cellular and humoral 
immune responses [10], are critical for the adaptive immune response to most viral 
infections [11]. CD3 T cells have been reported to be important for understanding the 
pathogenesis of  RSV. It has been emphasized that the role of  this immune response 
component should be considered in vaccine approaches to prevent RSV infections 
[11].
Nitric oxide (NO) is a gaseous inorganic radical produced endogenously in several 
cells and tissues. NO is involved in many important physiological functions, including 
blood vessel relaxation, inhibition of  platelet aggregation [12], regulation of  vascular 
tone, leukocyte adhesion, synaptic transmission, and cytostatic/cytotoxic actions 
of  macrophages [13]. Experimental fi ndings suggest that NO may play a role in 
immunological host defense mechanisms against pathogens and may be involved in 
signaling between macrophages and T cells [14,15]. In addition, NO is an antiviral 
effector of  the immune system [16,17] and can inhibit the proliferation of  various 
viruses [15,18,19]. It is produced from L-arginine via three different inducible NO 
synthases [20], namely, neuronal nitric oxide synthase (nNOS), inducible nitric oxide 
synthase (iNOS), and endothelial nitric oxide synthase (eNOS) [21].
Immunohistochemistry (IHC) staining is a safe method that facilitates the permanent 
and clear presentation of  antigen components [22], and it is frequently used in the 
diagnostic evaluation of  RSV antigens in formalin-fi xed tissues, including viral antigens 
[4,23]. In cattle, detailed immunoperoxidase studies on RSV have been reported [24, 
25]. However, there are only a few studies showing the presence of  RSV in naturally 
infected goats [4,26] and sheep [22] by the IHC method. The aim of  this study, was 
to evaluate the iNOS, CD3, and CD8 immune expression in RSV-positive naturally 
infected lamb pneumonia using the IHC method. 
MATERIAL AND METHODS
An abattoir survey for prevalence of  pneumonia in lambs was carried out on the lungs 
of  approximately 2100 lambs brought to the abattoir for slaughtering, which were 
predominantly male, originating from dairy and beef  herds of  Van, Turkey. The gross 
appearance of  lesions was recorded and totally 100 (4,8%) pneumonia-suspected and 
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10 control lung tissues were sampled. Tissue samples were collected at four different 
seasonal quarters of  the year (spring, summer, autumn, and winter). Thus, the effect of  
seasonal factors on the development of  the disease was examined, avoiding evaluation 
of  the RSV infection of  a specifi c region or fl ock at a specifi c time.
Histopathological examination
Lung tissue samples were taken from sacrifi ced lambs fi xed in 10% neutral formalin 
and embedded in paraffi n by routine methods. Sections 5 μm in thickness were 
cut for histological examination. The histopathological fi ndings were evaluated on 
hematoxylin-eosin (H&E) stained tissue slides using a light microscope (E-400; 
Nikon, Japan) equipped with a DS-Ri2 video camera (DS-U3, Nikon, Japan). The 
histopathological fi ndings were evaluated semi quantitatively according to the severity 
of  the lesions as (-) no lesion, (+) mild, (++) moderate and (+++) severe.
Immunohistochemical staining
The streptavidin-peroxidase method (ABC) was used to stain the sections. Slides 
were deparaffi nised and rehydrated. After quenching endogenous peroxidase activity 
with 3% H2O2 (v/v) for 20 min, the slides were washed twice in 0.01 M PBS for 5 
min. Heat-induced antigen retrieval was performed with citrate buffer (pH 6.0) for 
30 min at 95 °C using a water bath and by cooling for 20 min. Before adding the 
primary antibodies, the slides were incubated with blocking serum (Histostain Plus 
Bulk Kit, Zymed, USA) for 15 min to block nonspecifi c binding. All samples were 
incubated with polyclonal sera raised against RSV at 4°C overnight in a humidifi ed 
chamber. After incubation, the slides were washed four times in 0.01 M PBS for 5 min, 
incubated with biotinylated secondary antibody (Histostain Plus Bulk Kit, Zymed) 
for 20 min at room temperature (20-25°C), then washed four times in 0.01 M PBS 
for 5 min. After incubation with the secondary antibody, the sections were incubated 
with streptavidin-peroxidase (HRP) conjugate (Histostain Plus Bulk Kit, Zymed) 
for 20 min, then washed four times in 0.01 M PBS for 5 min following enzymatic 
incubation. To visualize the reactions, the sections were incubated for 5–15 min with 
diaminobenzidine (DAB). After the development of  the DAB reaction, the sections 
were counterstained with Gill’s haematoxylin. Then the sections were passed through 
alcohols and xylene and mounted directly with Entellan mounting medium. After RSV 
immunostaining, RSV positive samples were immunostained with antibodies for the 
detection of  iNOS, CD3 and CD8 T cells following the same staining protocol as 
above. The slides incubated with PBS instead of  primary antibodies served as negative 
controls to verify the immunostaining (Table 1). 
Immunohistochemical fi ndings were evaluated subjectively according to the intensity 
of  staining in the tissue as (-) negative, (+) mild, (++) moderate and (+++) intense, 
using a light microscope (E-400; Nikon, Japan) equipped with a DS-Ri2 video camera 
(DS-U3, Nikon, Japan).
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Table 1. Antibody specifi city, host, dilution rates and incubation times
Antibody Host Dilution Incubation Source
RSV Mouse 1/100 Overnight Thermo Fisher Sci-MA1-80661
anti-iNOS Rabbit 1/100 Overnight abcam-ab15323
CD3 Rabbit 1/100 Overnight Ventana-790-4341
CD8 Mouse 1/100 Overnight Novocastra-NCL-L-CD8-4B11
RESULTS
Macroscopic fi ndings
A total of  2100 lamb lungs were grossly examined, and pneumonia lesions consistent 
with RSV bronchointerstitial pneumonia were detected in 100 cases (4.8%). Pneumonic 
lesions were usually localized in the cranial lobes, comprising entire lobes or had a 
lobular pattern. The affected areas were dark red or gray-white and consolidated. 
The interlobular septa were dilated and demarcation lines were evident between the 
pneumonic and unaffected areas (Figure 1).
Histopathological fi ndings
Histopatholoy of  lung sections revealed predominantly bronchointerstitial (n=37; 
37%), catarrhal-purulent (n=17; 17%), or fi brinous (n=25; 25%) pneumonia. Areas 
Figure 1. Macroscopic appearance of  pneumonic lesions in a RSV-positive lung.
Lobe distributed, red-colored consolidated areas (stars)
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of  interstitial or bronchointerstitial pneumonia showed changes characterized by 
expansion of  the interalveolar walls as a result of  mononuclear cell infi ltration and 
congestion. The alveolar walls were lined with cuboidal type-2 pneumocytes, which are 
intrinsic to viral pneumonia. Fibromuscular hyperplasia was observed in some alveolar 
walls. Syncytial cell formation was found in the bronchi, bronchioles, and alveolar 
lumina. The interlobular septa were dilated due to mononuclear cell infi ltrations and 
edema. The exudate containing numerous neutrophils, cell debris, fi brin, erythrocytes, 
and macrophages was observed in the airways of  sections with exudative lesions 
(Figure 2).
Immunohistochemical fi ndings
The localisation and the frequency of  immunoreactivity for RVS, iNOS, CD3 and 
CD8  within the lung parenchyma in 18 RSV positive cases as confi rmed by IHC, are 
presented in Table 3, and the staining intenstity is presented in Table 2.
Table 2. The intensity of  IHC staining  for respiratory syncytial virus (RSV), inducible nitric 
oxide synthetase (iNOS), CD3 (pan T cells), and CD8 in the lung of  RSV positive cases
Case Immunoreactivity
with  RSV and 
the intensity of
the IHC signals*  
Immunoreactivity
with  iNOS and 
the intensity of
the IHC signals*   
Immunoreactivity
with  CD3 and 
the intensity of
the IHC signals*   
Immunoreactivity
with  CD8 and
the intensity of
the IHC signals*  
1 + ++ +++ -
2 ++ ++ - -
3 + + - -
4 + ++ +++ +
Figure 2. Lung, Lamb; Interstitial pneumonia. Syncytial cell formations (arrows) and 
proliferation of  type II epithelial cells in the wall of  alveoli (arrowheads); H&E, Bar = 50 μm.
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5 ++ +++ +++ +
6 +++ +++ +++ -
7 +++ ++ + -
8 ++ +++ ++ -
9 + + +++ +
10 ++ ++ +++ -
11 ++ +++ +++ +
12 +++ +++ ++ -
13 ++ ++ - -
14 + ++ +++ ++
15 ++ ++ +++ -
16 ++ + - -
17 +++ ++ + -
18 ++ + ++ -
*Amount of  antigen: - : negative; + : mild; ++ : moderate; +++ : intense
Anti-RSV staining
Immunohistochemical examinations revealed RSV positivity in 18 of  100 cases (18%). 
Positive immunostaining was detected in the areas of  bronchointerstitial pneumonia, 
with mostly mixed proliferative and exudative components. Immunoreactivity was 
observed in the cytoplasm of  the bronchial and bronchiolar epithelial cells, in the 
propria and submucosa, in the connective tissue around the bronchial glands, and 
in the exudate and cellular debris found in the bronchial and bronchiolar lumina. In 
addition, immunopositivity was determined in the cytoplasm of  infl ammatory cells in 
the interlobular and interalveolar septa in the cytoplasm of  macrophages, lymphocytes, 
and syncytial cells, and in the infl ammatory exudate and cell debris in the alveolar 
lumina (Table 3, Figure 3). No reaction was detected in the peribronchial lymphatic 
follicles (BALT). Finally, there was no positive staining in the control group tissues. 
Table 3. Distribution of  IHC stained antigens in the lung tissue. Data show the number of  


























RSV 10 12 15 17 8 6 14 3
iNOS 7 9 8 18 3 0 9 18
CD3 7 6 9 14 11 0 13 0
CD8 0 3 0 5 0 3 0 0
cont. Table 2.
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Anti-iNOS staining
Expression of  iNOS was seen in bronchial and bronchiolar epithelial cells in the lung 
sections of  the control group. In addition, iNOS immunoreactivity was observed in 
the capillary endothelium but not in most arteries. Compared with the control group, 
the increase in iNOS immunoreactivity was observed in arterial endothelial cells in all 
the RSV-positive samples, especially in acute phase pneumonia cases. Reactivity in the 
capillary endothelium was especially increased in the peribronchial and peribronchiolar 
areas. However, immunoreactivity in the bronchial and bronchiolar epithelium did not 
increase compared to the control group of  lambs. In addition, iNOS immunoreactivity 
was determined in the cytoplasm of  the alveolar macrophages and infl ammatory cells 
observed in the bronchial, bronchiolar, and alveolar lumina, and in the interstitium 
area. Immunoreactivity was not determined in neutrophils (Table 3, Figure 4).
Figure 3. RSV immunostaining in lung tissue; A) RSV immuno-positivity in epithelium of  
bronchi (arrowheads) and infl ammatory cells (arrows), Bar = 100 μm; B) RSV immuno-
positivity in epithelium of  bronchioli (Red arrows) and infl ammatory cells (arrowheads) in 
the alveolar lumina, Bar = 100 μm; C) RSV immunoreactivity in alveolar macrophages, Ba = 
100 μm; D) RSV immunoreactivity in macrophages and exudate in the alveolar lumina (arrows). 
ABC-P, Bar = 100 μm.
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Anti-CD3 staining
CD3+ T cells were seen in peribronchial lymphatic follicles in the lung sections of  
the control group. Pneumonic samples showing similar CD3 immunoreactivity to 
that of  the control group were considered negative. Fourteen (78%) RSV-positive 
sections showed an increase in CD3 immunoreactive CD3+ T cells. In these sections, 
immunoreactive CD3+ T cells were detected in the bronchial lymph nodes, epithelial 
lining, propria, and submucosa of  the bronchi and bronchioles, in all airway lumina, 
and in the intersitisyum around bronchial glands (Table 3, Figure 5).
Figure 4. iNOS immunostaining in lung tissue; A) In the lambs of  the control group, iNOS 
immunoreactivity was observed in the bronchiolar epithelial cells (arrows). Minimal reactivity 
was observed in the endothelium of  the great artery (arrowhead), Bar = 100 μm; B) iNOS 
immunoreactivity in capillary and arterial endothelium in RSV positive lambs, Bar=100 μm; 
C) iNOS immunoreactivity in alveolar macrophages in RSV positive lambs, Bar=100 μm; D) 
iNOS immunoreactivity in infl ammatory cells in alveolar lumen. ABC-P, Bar = 100 μm.
Acta Veterinaria-Beograd 2021, 71 (2), 170-188
178
Anti-CD8 staining
CD8+ T cells were not seen in the lung sections of  the control group. In fi ve (28%) of  
the RSV-positive sections, CD8+ T cells were detected in the propria and submucosa 
of  the bronchi and bronchioles, around the bronchial glands, and in the alveolar 
lumina (Table 3, Figure 6).
Figure 5. CD3 immunostaining in lung tissue; A) CD3+ T lymphocytes in a small number of  
cells in control lambs, Bar=100 μm; B) Common CD3+ T lymphocytes in RSV positive lambs, 
Bar=500 μm; C) CD3+ T lymphocytes in epithelial mucosa (arrows) and propria mucosa 
(arrowhead) of  bronch, Bar=100 μm; D) Common CD3+ T lymphocytes in propria mucosa 
and peribronchial area in RSV positive lambs. ABC-P, Bar=100 μm; E: Common CD3+ T 
lymphocytes in the airway epithelium (arrows), lumina (arrowhead) and around the airway 
(stars) in RSV positive lamb. ABC-P, Bar = 100 μm.
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DISCUSSION
Experimental RSV infection studies have been performed in many animal species 
[27-30]. There are studies describing the infl ammatory cells in the respiratory tract 
in lambs [31,32], cattle [33,34], and experimental animals [35] that were intentionally 
infected with RSV. However, such studies have not been conducted in lambs naturally 
infected with RSV. Although experimental RSV infections allow for the presentation 
of  clinical symptoms and lesions similar to those in native RSV infection, they do not 
fully refl ect the naturally occurring disease [36]. This is because host factors, such as age, 
immune status, pulmonary defense mechanisms, presence of  concurrent infections, 
and stress, can all determine the outcome of  respiratory infections. Therefore, it is 
important to establish an experimental population by thoroughly evaluating all animals 
and eliminating many of  these variables. In addition, it has been emphasized that 
Figure 6. CD8 immunostaining in lung tissues; A) No CD8 immunoreactivity was observed 
in the control group lambs, Bar=100 μm; B) CD8+ T lymphocytes in the propria mucosa 
(arrowhead) and submucosa (arrows) of  RSV positive lambs, Bar=100 μm; C) CD8+ T 
lymphocytes around the bronchial glands in RSV positive lambs (arrows), Bar=100 μm; D) 
CD8+ T lymphocytes in the alveolar lumina of  RSV positive lambs (arrows). ABC-P, Bar = 
100 μm.
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differences in inoculation may occur in studies conducted with experimental RSV; the 
volume, titer, and pathogenicity can determine the effectiveness of  the model [36]. In 
the present study, iNOS, CD3, and CD8 expression in infl ammation in natural RSV 
infections.
Diagnosis of  RSV is based on clinical fi ndings, macroscopic examination, 
histopathological fi ndings, and detection of  viral antigens by IHC in affected tissue 
sections [37,38]. However, sheep have been reported to be especially susceptible to 
viruses, such as parainfl uenza type-3 (PIV-3) and RSV [4,22]. The diagnosis of  these 
viruses is macroscopically limited, and since most respiratory viruses are known to 
destroy ciliary activity and signifi cantly reduce mucociliary clearance in the airway, 
they exhibit similar histopathological lung lesions [39,40]. Therefore, histological 
examination of  hematoxylin and eosin (H&E) sections is not suffi cient for causal 
diagnosis, as the pathological changes in the lung are similar in PIV-3 and RSV 
infections [2]. In addition, RSV has been reported to be diffi cult to isolate because 
it is a slowly progressing virus in cell culture [1,24]. Moreover, in RSV, the virus is 
rarely isolated in natural infections in sheep [41], and a RSV strain may cause severe 
pathological changes in lambs’ lungs without signifi cant clinical symptoms [31]. For all 
these reasons, the IHC technique is frequently used as a fast and reliable method for 
the detection of  RSV antigens in animals with respiratory diseases [22,25,42].
In our study, cytoplasmic RSV was detected in infl ammatory cells in the interalveolar 
septa; exudate in the alveolar lumina, alveolar macrophages, peribronchial and 
peribronchiolar area, and bronchial and bronchiolar epithelial cells; and cellular debris 
in bronchial and bronchiolar lumina (see Table 3 and Figure 3),  comparable to some 
previous studies [4,6,22,25,26]. Similar fi ndings in RSV infection have been reported 
in experimentally infected BALB/c mice [43].
NO has been reported to have an antimicrobial activity against various pathogens due 
to its cytotoxic or cytostatic effects [15]. In vivo, NO has been shown to signifi cantly 
contribute to the clearance of  certain viruses [44,45]. Several viruses, including 
infl uenza [15], adenovirus [46], and rhinovirus [47] have been reported to increase 
NO production in the respiratory epithelium, both in vitro and in vivo. In RSV infection 
of  respiratory epithelial cell culture, an increase in iNOS expression has been reported 
[48]. Stark et al. [49] reported that there was no signifi cant change in the intensity or 
distribution of  nNOS and eNOS after RSV infection compared with that in control 
mice. In contrast, iNOS staining increased signifi cantly, especially in the respiratory 
epithelium and on days 4 and 7 after RSV infection. Thus, IHC analysis has revealed 
that the major NOS enzyme that changes during acute RSV infection is iNOS in the 
respiratory epithelium [49]. Western blot analysis showed an increase in iNOS isoforms 
on days 4 and 7 after RSV infection, and iNOS was the primary NOS isoform showing 
an increase after RSV infection. In addition, this increase has been shown to occur in 
respiratory epithelial cells [49]. In the present study, iNOS expression was increased 
in the capillary and arterial endothelium compared with controls, but no increase was 
found in the bronchial and bronchiolar epithelium (see Table 3 and Figure 4).
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Infection of  respiratory epithelial cells with RSV resulted in the expression of  certain 
pro-infl ammatory proteins, including cytokines and chemokines (tumor necrosis factor 
[TNF]-α, interleukin [IL]-1α, IL-1β, IL-6, IL-8, [49,50]), receptor proteins [52,53], and 
other important cell signaling molecules, including NO. Expression of  iNOS has been 
identifi ed in macrophages, neutrophils, endothelial and smooth muscle cells, and the 
respiratory epithelium, and it has been reported to be transcriptionally regulated by a 
series of  pro-infl ammatory cytokines, such as TNF-α, interferon (IFN)-γ, IL-1β, and 
nuclear factor (NF)-κB [54,55]. Furthermore, NO is a key mediator in the interaction 
of  multiple cell types in respiratory infl ammation and facilitates the migration of  
infl ammatory cells into the airways [56]. Decreased numbers of  macrophages, 
lymphocytes, and neutrophils have been reported after iNOS inhibition. Thus, the 
greatest effect of  NO suppression is the reduction of  infl ammatory cells [49]. In our 
study, intense expression of  iNOS in infl ammatory cells and the vascular endothelium 
clearly revealed the role of  iNOS in natural RSV infection. It was observed that iNOS 
immunoexpression was especially formed in lymphocytes and alveolar macrophages, 
whereas immunoexpression was not seen in neutrophils (Table 3). Choi et al. [57] 
reported that the major cell types expressing iNOS in the infl ammation zone of  
tuberculosis granulomas are macrophages and multinucleated giant cells, but as 
expected, there was no iNOS expression in lymphocytes [57]. Therefore, it can be 
understood that the cell types in which iNOS is expressed may vary depending on the 
cause of  the infection.
The role of  NO in acute lung injury is controversial and has been shown to play 
benefi cial and harmful roles in various lung diseases, such as asthma, chronic obstructive 
pulmonary disease, cystic fi brosis, and acute lung injury [58,59]. NO activity in the lungs 
has been reported to be a double-edged sword: NO production contributes to both 
airway infl ammatory changes and respiratory dysfunction, in addition to increasing 
RSV clearance. It has been reported that RSV-induced NO production is involved in 
complex host responses and may mediate important aspects of  the disease [49].
T lymphocytes are the primary cellular immune responses of  RSV infection [7]. 
Immunohistochemically, the presence of  CD3 T cells was detected in RSV pneumonia 
primarily in the area between pulmonary arterioles and small distal airways at high 
density and occasionally in the infected airway epithelium. These cells were also 
present in the alveolar interstitium. Furthermore, CD3+ T lymphocytes have been 
reported to be an important component of  submuscular infl ammatory infi ltration 
around small bronchioles [11]. In our study, the presence of  CD3+ T lymphocytes was 
determined in similar areas. In addition, these cells were found to constitute most of  
the infl ammatory cells (see Table 3 and Figure 5).
Cytotoxic CD8 T cells play a critical role in the control and clearance of  RSV infection 
[60]. In lung lavage fl uid from BRSV-infected lambs, the presence of  CD8+ T 
lymphocytes was reported, compared with the fl uid obtained from the control group 
lambs [31]. Bovine CD8 T cells target the M2, F, N, and G proteins of  bRSV [33,34]. 
In mice and humans, the reactions of  CD4 and CD8 T cells are directed to epitopes 
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in most RSV proteins, including N, M, NS2, M2-1, F, and G [9]. As evidence of  their 
importance during infection, depletion of  CD8 T cells from bovine RSV-infected 
calves leads to more serious diseases and causes increased viral shedding compared 
with control animals [60]. In the present study, the presence of  CD8 T lymphocytes 
was detected in fi ve cases (see Table 3 and Figure 6).
In our research, the number of  CD8+ cases was found to be less than that of  CD3+ 
cases. This may be due to the duration of  the infection. In the study of  Sow  FB [7], 
in the lungs of  lambs infected with human RSV A2 strain, RSV titers were lower on 
day 3 after infection, markedly increased on day 6, and decreased to basal levels on 
day 14. In the same study, in the evaluation performed by fl ow cytometry, a signifi cant 
increase in CD1, CD4, and CD8 cell levels was detected at 6 days, and the macrophage 
infi ltration peak was observed on day 6. In another study [61], cytotoxic T cell activity 
was reported to peak at 7–10 days after infection. Although RSV induces a cytotoxic 
T cell response, this has been reported to be weak and transient [61,62]. In addition, 
large populations of  memory T cells remain in the airways and lung parenchyma, 
gradually decreasing within a few months and then stabilizing at a low level [63]. In 
our study, the duration of  infection could not be determined because the animals from 
which the samples were taken were naturally infected. Therefore, we think that the 
lymphocytes involved in the infection may vary accordingly. However, the detection 
of  CD3+ T lymphocytes in most RSV-positive cases (77%) clearly demonstrates that 
these cells play an important role in RSV infection.
Neutrophils produce a wide range of  infl ammatory products, including oxidants and 
proteolytic enzymes, and they play a role in the development of  acute and chronic 
lung disease [64,65]. RSV immune complexes have been shown to stimulate neutrophil 
activity [66]. RSV infection stimulates human alveolar macrophages [67] and airway 
epithelial cells [68] to produce large amounts of  IL-8. In turn, IL-8 is known to be 
a potent chemotactic and activator for neutrophils [69], and this cytokine is likely 
to play a central role in the neutrophil fl ow seen in RSV infections. In the present 
study, H&E examination of  the lung sections of  RSV-positive animals showed that 
neutrophils were predominantly present in the infl ammation cells. Although the level 
of  neutrophils has been reported to increase due to the presence of  bacterial agents, 
such as Mannheimia and Mycoplasma [25], in  light of  the above literature data, it may be 
thought that neutrophils play an important role in the immune response to RSV.
The macroscopic and histopathological fi ndings of  this study were consistent with the 
studies previously reported in sheep [22,70], goats [4], and cattle [25,42]. Most of  the 
macroscopic lesions were lobular and consisted of  consolidated red or greyish-white 
lung tissue, especially in the cranial lobes of  the lung. Demarcation lines were prominent 
between the pneumonic lobes and unaffected areas [22,42]. However, as previously 
noted in studies on natural RSV infections, it is unclear to what degree the described 
lesions result from the additional or synergistic effect of  combined pathogens [22,25]. 
This is because the presence of  other pulmonary pathogens, such as adenovirus, P. 
haemolytica, P. multocida, and Mycoplasma spp., has been reported to cause simultaneous 
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infections with RSV. In addition, RSV has been reported to increase susceptibility to 
secondary bacterial infections, such as P. multocida and M. haemolytica [25].
The fi ndings of  our study contribute to the understanding of  RSV pathogenesis and 
may simplify the development of  new approaches for prevention and treatment. The 
increase in the immune expression of  iNOS and CD3 in most of  the RSV-positive 
cases showed that they play an important role in the immune response. However, the 
effects of  the presence of  other possible pathogens on their expression could not be 
ignored, since cases of  a natural infection were examined.
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INFEKCIJA RESPIRATORNIM SINCICIJALNIM VIRUSOM 
INDUKUJE EKSPRESIJU INDUSIBILNE AZOT OKSID
SINTAZE, CD3, I CD8 KOD PNEUMONIJE JAGNJADI
Turan YAMAN, Ceyhun AYDEMİR
Respiratorni sincicijalni virus (RSV) je RNK virus koji pripada rodu Pneumovirus iz 
porodice Paramyxoviridae. Cilj ove studije bio je da se proceni ekspresija inducibilne 
sintetaze azotnog oksida (iNOS), CD3 (pan T ć elija) i CD8 (citotoksičnih T ć elija) 
u pluć ima jagnjadi prirodno infi cirane RSV-om primenom imunohistohemije (IHC). 
U tu svrhu uzeto je 100 uzoraka pluć a i 10 kontrolnih uzoraka pluć nog tkiva jagnjadi 
zaklanih u klanici, nakon makroskopskog pregleda. Za IHC bojenje korišć ena je 
metoda streptavidin-peroksidaze (ABC) koja je otkrila pozitivnost RSV u 18 od 100 
pregledanih pneumoničnih pluć a (18%).
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Ovi pozitivni slučajevi su zatim imunohistohemijski  obrađeni za iNOS, CD3 i CD8 
i upoređeni sa kontrolama. U svim ovim slučajevima otkriven je porast ekspresije 
iNOS (100%), već i broj CD3 + T limfocita otkriven je u 14 (78%) slučajeva, dok su 
CD8 + T limfociti dokayani samo u pet (28%) slučajeva. S obzirom na poveć anje 
iNOS imunoekspresije u svim RSV-pozitivnim slučajevima i poveć anje broja CD3 
+ T limfocita u već ini slučajeva, zaključeno je da iNOS i CD3 + T limfociti igraju 
važnu ulogu u imunskom odgovoru kod  RSV pneumonije jagnjadi  koja se prirodno 
javlja. Ovom studijom je prvi put procenjena uloga pomenutih markera kod jagnjadi 
prirodno zaraženih RSV-om.
